US Patent Issued to ARBUTUS BIOPHARMA on March 18 for "Lipid nanoparticle formulations" (Canadian, American Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,470, issued on March 18, was assigned to ARBUTUS BIOPHARMA Corp. (Burnaby, Canada).

"Lipid nanoparticle formulations" was invented by James Heyes (Vancouver, Canada), Adam Judge (Bainbridge Island, Wash.), Kieu Mong Lam (Richmond, Canada), Lorne Ralph Palmer (Vancouver, Canada) and Petra Schreiner (Burnaby, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides certain specific lipid nanoparticles comprising: (a) one or more nucleic acid molecules; (b) cholesterol; (c) DSPC; (d) PEG-C-DMA; and (e) a cationic lipid; and pharmaceutical compositions comprising the lipid nanoparticles. The lipid nanoparticles and pharmaceutical co...